Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 219

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 219
---
 of approximately $based on the closing price of $per Public Warrant on the Record Date. Because the Public Warrants will remain outstanding and become Company Warrants regardless of the level of redemptions of Public Shares, as redemptions of Public Shares increase, the holders of Company Warrants who exercise such warrants will ultimately own a greater interest in the Company because there would be fewer Company Shares outstanding overall. APx has no contractual obligation to notify warrant holders that the APx Warrants have become eligible for redemption and do not intend to so notify upon eligibility of the APx Warrants for redemption, unless and until APx elects to redeem such APx Warrants pursuant to the terms of the SPAC Warrant Agreement. Pursuant to the terms of the SPAC Warrant Agreement, if APx elects to redeem all of the redeemable APx Warrants as described above, APx will fix a date for the redemption (the “Redemption Date”) and will mail the notice of redemption by first class mail, postage prepaid, not less than 30 days prior to the Redemption Date to the registered holders of the APx Warrants to be redeemed at their last addresses as they appear on APx’s registration books; provided that holders will be able to exercise their APx Warrants prior to the Redemption Date and, at APx’s election, any such exercise may be required to be on a cashless basis. Any noticed mailed in the aforementioned manner shall be conclusively presumed to have been duly given whether or not the registered holder received such notice. APx Warrants will become exercisable for Company Shares, which would increase the number of shares eligible for future resale in the public market and result in dilution to shareholders of APx. If the Business Combination is completed, outstanding APx Warrants to purchase an aggregate of 17,575,000 Company Shares will become exercisable in accordance with the terms of the SPAC Warrant Agreement governing those securities. The APx Warrants will become exercisable 30 days after the completion of the Business Combination. The exercise price of the APx Warrants will be $11.50 per share. To the extent such APx Warrants are exercised, additional Company Shares will be issued, which will result in dilution to the holders of Company Shares and increase the number of Company Shares eligible for resale in the public market. The dilution, as a percentage of outstanding Company Shares, caused by the exercise of the APx Warrants will increase if a large number of our